Principle Wealth Partners’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-24	Closed	-$2K	–	211
2020 Q2	$2K	Buy	+24	New	+$2K	﹤0.01%	455